
Low Stock — 7 leftBest Seller
Retatrutide 30mg
Triple Receptor Agonist Research Peptide
30mg / 3ml vial · 10mg/ml · Metabolic
£220.00
✓ In Stock — UK
About Retatrutide 30mg
Triple GIP/GLP-1/glucagon receptor agonist — a next-generation compound studied in metabolic, incretin and energy-metabolism research. Supplied for laboratory and research use only.
Specifications
| Purity | >99.7% |
| Volume | 3ml |
| Storage | 2–8°C |
| Shelf life | 1 month |
| Concentration | 10mg/ml |
| Total content | 30mg per pen |
Order from UK Stock
- ✓ >99.7% purity — third-party ISO 17025 tested
- ✓ UK stock — ships 1–2 working days
- ✓ Free delivery on orders over £150
- ✓ Insulated freeze bags with every order to preserve potency
- ✓ Certificate of Analysis with every batch
GLP-1GIPglucagonmetabolicappetite regulationincretinreceptor agonist
Related Research Peptides
Research Use Only — Retatrutide 30mg is supplied strictly for research and laboratory use. Not intended for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease. For research use only.